Please select the eligibility criteria that correspond to the clinical trial below.
Title: Mindfulness Based Relapse Prevention: Efficacy and Mechanisms
Brief Summary: The broad, long-term objective of the proposed randomized clinical trial is to evaluate the efficacy, moderators and mechanisms of change of two cognitive-behavioral aftercare treatments for alcohol and other drug (AOD) use disorders in preventing AOD relapse compared to treatment as usual (TAU) offered in the community. The two cognitive-behavioral aftercare treatments are relapse prevention (RP) and Mindfulness-Based Relapse Prevention (MBRP), which integrates mindfulness meditation and RP aftercare components.


Options:
A: Inclusion Criteria:

To be eligible for the study participants must:

1. Be 18 years or older
2. Live in RI or MA within 20 miles of Providence and plan to remain in the area for the next 6 months
3. Meet DSM-IV criteria for alcohol abuse or dependence in the last six months
4. Do not expect to attend residential alcohol or drug treatment upon release
5. Report STI/HIV sexual risk defined as unprotected heterosexual sex at least three times in the three months prior to incarceration
6. Speak English.
7. Be currently held at the Rhode Island Adult Correctional Institutions Jail facility

Women will be excluded from participation if they:

1. Cannot provide the name of at least two locator persons who will know where they can be found.
B: Inclusion Criteria:

* 18 yo
* meets Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for alcohol dependence

Exclusion Criteria:

* acute medical or psychiatric problems that require inpatient treatment (e.g., acute psychosis, or suicide/homicide risk)
* reading ability below the fifth grade level
* lack of reliable transportation to the treatment site, or excessive commuting distance
* inability to understand English
C: Inclusion Criteria - Women with a diagnosis of substance abuse or dependence who also have either full or sub-threshold DSM-IV PTSD.

Exclusion Criteria:

- Women will be excluded from the study who have current psychotic disorders, or a history of active psychosis (past two months); women with a diagnosis of substance abuse or dependence who also have either full or sub-threshold DSM-IV PTSD; and women who have current psychotic disorders, or a history of active psychosis (past two months).
D: Inclusion Criteria:

* completion or scheduled completion (i.e., within 2 weeks) of Inpatient or Intensive Outpatient treatment
* fluency in English
* enrollment in a substance abuse aftercare program
* medical clearance by referring provider
* willingness to accept random assignment to treatment condition

Exclusion Criteria:

* already participated in the pilot MBRP trial conducted by this research team
* participation in the comorbid disorders or relapse prevention groups offered at partner agency
* comorbid psychosis (including schizophrenia, schizoaffective or other schizophreniform disorder)and/or dementia, acute suicidality/intent to harm others, severe cognitive impairment, and high risk of withdrawal or medical complications stemming from relapse which would require a higher level of care.

Answer: D